Aug 24, 2026 08:15AM
Aug 14, 2026 04:00PM
Jul 28, 2026 08:02AM
Jul 28, 2026 08:00AM
Jun 2, 2026 09:00AM
May 28, 2026 07:45AM
May 28, 2026 07:45AM BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors
May 19, 2026 08:04AM
May 19, 2026 08:00AM
May 15, 2026 04:05PM
Mar 31, 2026 04:01PM
Feb 26, 2026 06:23AM
Feb 26, 2026 06:22AM
Feb 20, 2026 06:01AM BrainStorm raises $1 million in private placement at premium pricing
Feb 20, 2026 06:00AM
Nov 14, 2025 04:30PM
Aug 14, 2025 07:02AM
Aug 8, 2025 07:00AM
Jul 17, 2025 04:31PM
Jul 17, 2025 04:30PM
Jul 17, 2025 04:30PM BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB
Jul 8, 2025 07:01AM
Jul 8, 2025 07:00AM
Jun 16, 2025 08:30AM
May 27, 2025 07:04AM
May 27, 2025 07:00AM
May 19, 2025 07:01AM
May 19, 2025 07:00AM BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn® for ALS
May 15, 2025 04:05PM
May 15, 2025 07:30AM
May 7, 2025 06:30AM
May 6, 2025 07:00AM
Apr 29, 2025 06:30AM
Apr 10, 2025 07:30AM
Apr 10, 2025 07:30AM BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn® in ALS
Mar 31, 2025 07:00AM
Mar 26, 2025 08:15AM
Mar 26, 2025 08:15AM
Mar 24, 2025 07:00AM
Dec 30, 2024 08:00AM
Dec 30, 2024 08:00AM
Dec 9, 2024 07:00AM BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update
Dec 3, 2024 07:05AM
Dec 3, 2024 07:00AM
Dec 2, 2024 07:00AM
Nov 14, 2024 04:30PM
Nov 11, 2024 06:00AM
Oct 30, 2024 07:58AM
Oct 30, 2024 06:01AM Brainstorm Cell Therapeutics (BCLI) Regains Nasdaq Compliance
Oct 30, 2024 06:00AM

329,957 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All